[Federal Register: April 1, 2004 (Volume 69, Number 63)]
[Notices]
[Page 17157-17158]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr01ap04-82]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-23-04]
Proposed Data Collections Submitted for Public Comment and
Recommendations
The Centers for Disease Control and Prevention (CDC) publishes a
list of information collection requests under review by the Office of
Management and Budget (OMB) in compliance with the Paperwork Reduction
Act (44 U.S.C. Chapter 35). To request a copy of these requests, call
the CDC Reports Clearance Officer at (404) 498-1210. Send written
comments to CDC, Desk Officer, Human Resources and Housing Branch, New
Executive Office Building, Room 10235, Washington, DC 20503 or by fax
to (202) 395-6974. Written comments should be received within 30 days
of this notice.
Proposed Project: Descriptive Epidemiology of Missed or Delayed
Diagnoses for Conditions Detected by Newborn Screening--New--National
Center for Environmental Health (NCEH), Centers for Disease Control and
Prevention (CDC).
Every state in the United States and Washington, DC, has a public
health program to test newborn babies for congenital metabolic and
other disorders through laboratory testing of dried blood spots. These
programs screen for between 4 and 30 different conditions including
phenylketonuria (PKU) and congenital hypothyroidism, with testing
performed in both state laboratories and private laboratories
contracted by state health departments. The screening process or system
is broader than the state public health newborn screening program,
which is composed only of the laboratory and follow-up personnel. It
involves the collection of blood from a newborn, analysis of the sample
in a screening laboratory, follow-up of abnormal results, confirmatory
testing and diagnostic work-up. Parents, hospitals, medical providers
including primary care providers and specialists, state laboratory and
follow-up personnel advocates, as well as other partners such as local
health departments, police, child protection workers, and courts play
important roles in this process.
Most children born with metabolic disease are identified in a
timely manner and within the parameters defined by the newborn
screening system of each state. These children are referred for
diagnosis and treatment. However, some cases are not detected at all or
the detection comes too late to prevent harm. These ``missed cases''
often result in severe morbidity such as mental retardation or death.
In this project, we will update and expand a previous
epidemiological study of missed cases of two disorders published in
1986. We will assess the number of cases of each disorder missed, and
the reasons for the missed and legal outcomes, if any. The reasons for
the missed will be tabulated according to which step or steps of the
screening process it occurred. Data will be collected by asking state
public health laboratory directors, newborn screening laboratory
managers, follow-up coordinators, specialists at metabolic clinics and
parent groups with an interest in newborn screening, for information
regarding missed cases. An estimated 269 subjects (with an expected
response rate of 80% from metabolic clinics, Lab Directors and
Coordinators) will be requested to complete a short questionnaire that
asks for information regarding the details of any missed cases of which
they are aware.
The survey will highlight procedures and actions taken by states
and other participants in newborn screening systems to identify causes
of missed cases and to modify policies and procedures to prevent or
minimize recurrences. The information gleaned from this study may be
used to help craft changes in the screening protocols that will make
the process more organized and efficient and less likely to fail an
affected child. Furthermore, it is not clear that there is a systematic
[[Page 17158]]
assessment of missed cases on a population basis; this project will
seek to identify procedures for routine surveillance of missed cases.
The estimated annualized burden is 36 hours.
------------------------------------------------------------------------
Number of Average
Number of responses burden per
Respondents respondents per response (in
respondent hours)
------------------------------------------------------------------------
Lab Directors................. 42 1 10/60
Follow-up Coordinators........ 42 1 10/60
Metabolic Clinic Employee..... 120 1 10/60
Parent Advocate............... 13 1 10/60
------------------------------------------------------------------------
Dated: March 25, 2004.
Joe E. Salter,
Acting Director, Management Analysis and Services Office, Centers for
Disease Control and Prevention.
[FR Doc. 04-7311 Filed 3-31-04; 8:45 am]
BILLING CODE 4163-18-P